CeriBell, Inc. (NASDAQ:CBLL) Receives Average Rating of “Moderate Buy” from Analysts

Shares of CeriBell, Inc. (NASDAQ:CBLL) have been given a consensus rating of “Moderate Buy” by the six research firms that are currently covering the firm, Marketbeat Ratings reports. One analyst has rated the stock with a sell recommendation, four have given a buy recommendation and one has given a strong buy recommendation to the company. The average 12 month price target among brokers that have issued a report on the stock in the last year is $22.20.

A number of equities analysts have recently weighed in on the company. Canaccord Genuity Group lowered their target price on CeriBell from $28.00 to $25.00 and set a “buy” rating on the stock in a research note on Tuesday, May 12th. Weiss Ratings raised CeriBell from a “sell (e+)” rating to a “sell (d-)” rating in a research report on Wednesday, May 27th.

CeriBell Price Performance

Shares of NASDAQ CBLL opened at $18.50 on Wednesday. The firm has a market cap of $701.89 million, a P/E ratio of -11.35 and a beta of 0.84. The company has a current ratio of 10.44, a quick ratio of 10.01 and a debt-to-equity ratio of 0.14. CeriBell has a 1-year low of $10.85 and a 1-year high of $24.33. The business’s 50 day moving average is $18.97 and its 200-day moving average is $19.63.

CeriBell (NASDAQ:CBLL) last announced its earnings results on Monday, May 11th. The company reported ($0.52) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.39) by ($0.13). The firm had revenue of $26.49 million for the quarter, compared to the consensus estimate of $26.09 million. CeriBell had a negative return on equity of 38.19% and a negative net margin of 63.51%. Equities research analysts predict that CeriBell will post -1.69 earnings per share for the current year.

Insider Buying and Selling

In related news, CTO Raymond Woo sold 1,966 shares of the stock in a transaction that occurred on Thursday, May 21st. The stock was sold at an average price of $18.00, for a total transaction of $35,388.00. Following the sale, the chief technology officer owned 195,682 shares of the company’s stock, valued at $3,522,276. This represents a 0.99% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available through the SEC website. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, CEO Xingjuan Chao sold 6,030 shares of the stock in a transaction that occurred on Thursday, May 21st. The stock was sold at an average price of $18.00, for a total value of $108,540.00. Following the sale, the chief executive officer directly owned 830,317 shares in the company, valued at $14,945,706. This represents a 0.72% decrease in their position. The SEC filing for this sale provides additional information. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Insiders have sold 112,826 shares of company stock worth $2,162,374 in the last three months. 20.10% of the stock is currently owned by company insiders.

Institutional Investors Weigh In On CeriBell

Large investors have recently added to or reduced their stakes in the stock. Caitong International Asset Management Co. Ltd grew its position in CeriBell by 3,971.0% during the fourth quarter. Caitong International Asset Management Co. Ltd now owns 1,262 shares of the company’s stock worth $28,000 after buying an additional 1,231 shares in the last quarter. Strs Ohio acquired a new stake in shares of CeriBell in the 1st quarter valued at $27,000. CWM LLC boosted its holdings in shares of CeriBell by 1,178.5% in the 4th quarter. CWM LLC now owns 1,841 shares of the company’s stock valued at $40,000 after purchasing an additional 1,697 shares in the last quarter. Tower Research Capital LLC TRC boosted its holdings in shares of CeriBell by 353.8% in the 2nd quarter. Tower Research Capital LLC TRC now owns 2,310 shares of the company’s stock valued at $43,000 after purchasing an additional 1,801 shares in the last quarter. Finally, Larson Financial Group LLC boosted its holdings in shares of CeriBell by 1,403.1% in the 4th quarter. Larson Financial Group LLC now owns 2,871 shares of the company’s stock valued at $63,000 after purchasing an additional 2,680 shares in the last quarter.

About CeriBell

CeriBell Corp (NASDAQ: CBLL) is a healthcare technology company specializing in the design, manufacture and sale of automated newborn hearing screening devices. The company offers a suite of medical diagnostic tools based on otoacoustic emissions (OAE) and auditory brainstem response (ABR) technologies, enabling early detection of auditory impairments in infants. CeriBell’s solutions are used in hospitals, birthing centers and audiology clinics to support universal newborn hearing screening programs aimed at improving language development outcomes through prompt intervention.

The company’s product portfolio includes handheld and desktop screening units, proprietary software for data management, and accessories designed to streamline testing workflows.